GLP-1 patches are widely available online, but there is currently no evidence that commercially available patches contain FDA-approved GLP-1 receptor agonist medications, despite what the name implies
While preclinical studies have provided important mechanistic insights into the CV effects of GLP-1RAs, many experimental models of atherosclerosis, MI, or heart failure were conducted in mice that, despite being fed an HFD or HCD, do not develop the severe obesity or T2D that characterize patients treated with GLP-1RAs in CVOTs
Q5: Can glutathione injections eliminate dark spots
Repeat potassium level if pseudohyperkalemia/hemolysis is highly suspected
In fact, logically, lower doses are likely to mean fewer side-effects
PMID: 6 MarsoSPBainSCConsoliAEliaschewitzFGJdarELeiterLAet al